These 10 companies are ones to look out for. Getty Images

From fast-charging batteries and hydrogen fuel alternatives to metals recycling and artificial intelligence-driven data tools, energy tech startups have a lot to offer the industry.

After nearly 60 pitches, the Rice Alliance for for Technology and Entrepreneurship named 10 startups to look out for in the energy industry. The announcement was made at the conclusion of the annual Energy and Clean Technology Venture Forum hosted at Rice University on September 11.

Of the 10, five hail from Houston. Check out this year's energy tech startups to look out for.

Sensytec

Fresh off a win from Houston's inaugural MassChallenge Texas cohort, Houston-based Sensytec again scored big. Sesnsytec's technology is known as the "smart concrete" because they've created a device that can be embedded into concrete and monitor its structure in real time. The company was founded out of the University of Houston in 2016 by Ody de la Paz.

Rheidiant

Another Houston-based company, Rheidiant uses industrial Internet of Things to optimize data from the pipelines. As a result, Rheidiant's technology can increase productivity, reduce leaks, quickly respond in emergency situations, and enhance visibility in the field. Rheidiant was founded in 2014 by CEO Murat Ocalan.

Nesh

Houston-based Nesh has created a smart assistant for oil and gas. Using artificial intelligence, Nesh can answer any question from an oil and gas employee to improve their decision-making process and cut down on the time it takes to find solutions. Nesh was founded in 2018 by Sidd Gupta and the company closed its seed round in April.

GBatteries

GBatteries, based in Ottawa, Canada, is changing the lithium battery charging game. With a mission of revolutionizing the electric car industry, GBatteries has created an artificial intelligence-backed technology that can charge a lithium battery to half full in 5 minutes. The company has 10 patents granted and 28 pending and has pilot programs in the works with automotive companies.

HARBO Technologies

Tel Aviv, Israel-based HARBO Technologies bills itself as the fastest and most effective oil spill response system in the world.The company's T-Fence system can be deployed quickly and by a team of as little as two people. HARBO was founded in 2013 by CEO Boaz Ur and has raised three rounds of funding, according to Crunchbase.

Sensorfield

It's not the first time Houston-based Sensorfield has been deemed most promising by the Rice Alliance. The company has created easy to install, wireless devices for monitoring throughout the industrial process. In May, the startup was selected for Chevron Technology Ventures' Catalyst Program.

MolyWorks Materials Corp.

California startup, MolyWorks Materials Corp., is improving the way industrial materials are recycled by building by creating a network of distributed recycling and additive manufacturing. Old metals materials go in, and metallic powder for manufacturing new products come out.

Lilac Solutions

Oakland, California-based Lilac Solutions exists to enhance lithium production as the demand rises with the growth of the electronic vehicles industry. Lilac has created a unique ion exchange technology that can lower the cost of lithium production while increasing the speed. The company is currently operating pilot programs.

Mission Secure

Mission Secure Inc. has created an industrial control system that can protect energy companies from potential cybersecurity threats as well as educate on the process. Based in Charlottesville, Virginia, MSI is venture backed and serving clients in Houston.

Syzygy Plasmonics

Houston-based Syzygy Plasmonics is fresh off a $5.8 million series A funding round it closed in August. The company is creating a hydrogen fuel cell technology that produces a cheaper source of energy that releases fewer carbon emissions. The hydrogen-fueled technology originated out of research done over two decades by two Rice University professors, Naomi Halas and Peter Nordlander. Earlier this summer, the Rice Alliance named Syzygy a most promising startup at the Offshore Technology Conference.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.